Total Payments
$9,857
2024 Payments
$2,255
Companies
71
Transactions
461
Medicare Patients
4,343
Medicare Billing
$4.1M
Payment Breakdown by Category
Food & Beverage$9,758 (99.0%)
Education$99.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,758 | 460 | 99.0% |
| Education | $99.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $972.71 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $776.73 | 34 | $0 (2024) |
| Amgen Inc. | $637.70 | 24 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $616.12 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $498.53 | 35 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $409.32 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $408.31 | 23 | $0 (2024) |
| Daiichi Sankyo Inc. | $392.64 | 19 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $293.56 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $291.11 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,255 | 92 | Merck Sharp & Dohme LLC ($232.86) |
| 2023 | $1,850 | 64 | Myriad Genetic Laboratories, Inc. ($293.56) |
| 2022 | $688.91 | 34 | Seagen Inc. ($163.51) |
| 2021 | $480.17 | 21 | Amgen Inc. ($78.05) |
| 2020 | $134.92 | 7 | Celgene Corporation ($24.78) |
| 2019 | $1,739 | 96 | Merck Sharp & Dohme Corporation ($189.82) |
| 2018 | $1,651 | 88 | Novartis Pharmaceuticals Corporation ($319.82) |
| 2017 | $1,057 | 59 | Novartis Pharmaceuticals Corporation ($257.23) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Genetically Defined Disease | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Oncology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $33.08 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/28/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: Oncology | ||||||
| 10/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.83 | General |
| 09/26/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $37.81 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,103 | 6,352 | $4.2M | $951,559 |
| 2022 | 31 | 1,190 | 5,658 | $4.0M | $1.0M |
| 2021 | 30 | 1,062 | 4,489 | $5.1M | $1.2M |
| 2020 | 23 | 988 | 5,404 | $3.5M | $917,434 |
Total Patients
4,343
Total Services
21,903
Medicare Billing
$4.1M
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 37 | 547 | $1.1M | $219,352 | 19.7% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 41 | 460 | $344,195 | $120,580 | 35.0% |
| G0340 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | Office | 2023 | 15 | 46 | $682,051 | $106,445 | 15.6% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 61 | 744 | $346,230 | $94,384 | 27.3% |
| G6013 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | Office | 2023 | 16 | 157 | $122,705 | $41,271 | 33.6% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 20 | 21 | $138,516 | $39,273 | 28.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 70 | 216 | $198,433 | $38,727 | 19.5% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 74 | 299 | $190,735 | $37,867 | 19.9% |
| G0339 | Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | Office | 2023 | 12 | 12 | $163,960 | $37,790 | 23.0% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 62 | 104 | $84,665 | $30,093 | 35.5% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 17 | 17 | $116,250 | $29,037 | 25.0% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 37 | 52 | $75,308 | $25,128 | 33.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 65 | 356 | $115,302 | $23,499 | 20.4% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 81 | 234 | $77,566 | $22,083 | 28.5% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 29 | 30 | $112,673 | $14,524 | 12.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $36,280 | $12,897 | 35.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 21 | 25 | $37,169 | $11,453 | 30.8% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 63 | 65 | $59,070 | $10,162 | 17.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 43 | $19,988 | $7,358 | 36.8% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 11 | 11 | $16,092 | $4,871 | 30.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 16 | 16 | $18,446 | $4,605 | 25.0% |
| 77307 | Complex radiation therapy planning for delivery of external radiation | Office | 2023 | 15 | 15 | $16,688 | $4,380 | 26.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 80 | 87 | $22,223 | $4,263 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 56 | $14,096 | $4,051 | 28.7% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 14 | 91 | $16,420 | $3,482 | 21.2% |
About Dr. Gopal Sachdeva, MD
Dr. Gopal Sachdeva, MD is a Radiation Oncology healthcare provider based in Emeryville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447449509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gopal Sachdeva, MD has received a total of $9,857 in payments from pharmaceutical and medical device companies, with $2,255 received in 2024. These payments were reported across 461 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($9,758).
As a Medicare-enrolled provider, Sachdeva has provided services to 4,343 Medicare beneficiaries, totaling 21,903 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Emeryville, CA
- Active Since 10/15/2007
- Last Updated 09/24/2015
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1447449509
Products in Payments
- KEYTRUDA (Biological) $757.15
- NINLARO (Drug) $275.95
- INJECTAFER (Drug) $232.64
- PADCEV (Biological) $194.69
- Kyprolis (Biological) $190.47
- PROLARIS (Device) $186.06
- LIBTAYO (Biological) $181.57
- Nplate (Biological) $178.57
- KISQALI (Drug) $175.56
- Stivarga (Drug) $169.63
- IMBRUVICA (Drug) $165.27
- ADCETRIS (Biological) $164.04
- TAGRISSO (Drug) $161.74
- IMFINZI (Biological) $151.76
- Enhertu (Drug) $148.15
- PYLARIFY (Drug) $146.91
- AFINITOR (Drug) $146.41
- OPDIVO (Biological) $144.33
- ERLEADA (Drug) $144.00
- Flexitouch Plus (Device) $136.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.